Assessment of CR8020, a Monoclonal Antibody Against Influenza A Viruses

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to assess in healthy subjects the safety, tolerability, pharmacokinetics and immunogenicity of single escalating doses of CR8020, a monoclonal antibody against influenza A viruses.
Epistemonikos ID: 5985dda79d46001526498d586f0a86d2d8dbceb6
First added on: Mar 23, 2020